Gabriel C. Palafox

🇲🇽🎗️🧬Rad Onc| ☢️🧠Radiosurgereon | @HOCMNSXXI |Kumi & Blackie 🐶🐶

[Gabriel C. Palafox @oncontrerasp]

@viajaVolaris muchas gracias por la atención y resolución a mi caso . Realmente era muy importante este vuelo .

[Gabriel C. Palafox @oncontrerasp]

@viajaVolaris @Profeco

[Gabriel C. Palafox @oncontrerasp]

Que está pasando @viajaVolaris Culiacán . Sobre vendiendo boletos . Existen personas que trabajamos a primera hora y no nos asignas asiento . Pésimo servicio @Profeco vuelo: Y4391 Culiacán - CDMX

[Gabriel C. Palafox @oncontrerasp]

El silencio no es casualidad: Es un mecanismo de defensa del ego. #leccionaprendida

[Gabriel C. Palafox @oncontrerasp]

La radioterapia no solo elimina células: también enciende esperanzas.
#Halloween #CancerResearch #CancerAwareness #childhoodcancer
#radioterapia #infancia #mxtxtober2025

[PETHEMA @_pethema]

📢 Webinar: Leucemia Linfoblástica Aguda R/R. Un enfoque basado en casos clínicos
🗓️ Jueves 18/09/2025 | 🕓 16:00–18:00 🎯 Objetivo: mejorar el abordaje terapéutico y compartir lecciones clave de casos reales. 6/6
#Leucemia #LLA #Oncología #CAR_T #Hematología #WebinarMédico

[Gabriel C. Palafox @oncontrerasp]

Qué novedad con la puntualidad @viajaVolaris

[Claudio X. González G. @ClaudioXGG]

Caray.

[Doc Navarrow @DocNavarrow]

👨‍🦲62M presents with progressive right-sided ptosis, ophthalmoplegia, and intense supraorbital pain unresponsive to analgesics. Months later, hypoesthesia in V1/V2 distribution appears. History of multiple facial skin tumors.

❔What could be causing his cavernous sinus syndrome?

[Alireza Mansouri @DrAMansouri]

The tremendous impact of SRS for brain metastases is felt everyday for our patients. Left image showing one of many lesions but this one affecting the midbrain and thalamus. Right image showing substantial response within 2 months. Patient doing great!

[Gabriel C. Palafox @oncontrerasp]

Hoy quiero reflexionar sobre una inquietud que muchos de nosotros hemos compartido en algún momento: ¿Por qué, en muchos contextos, parece que se premia la mediocridad ?

[Praveen Kumar Marimuthu @drmpk91]

Immunotherapy for advanced-stage squamous cell lung cancer
https://t.co/nT00EI7b6b
@NatRevClinOncol
#LCSM

[Nicholas Zaorsky, MD MS @NicholasZaorsky]

Epidural spinal cord compression (ESCC) scale for cancer metastasis

[Gustavo @gusviani]

🚨 Should RT Dose Be Personalized in NSCLC with Actionable Mutations?@OncoAlert
A real-world multicenter study explores dose escalation in EGFR/ALK+ 👥
🎯 Objective
•Investigate if standard RT doses are sufficient for NSCLC 👥 w/ EGFR/ALK mutations, given their unique tumor biology
🏥 Methods
•Multicenter retrospective study
•Patients: NSCLC Stage III w/ actionable mutations
•☢️Dose: Standard (60-66 Gy) vs. escalated dose
•🎯: Local control, OS & toxicity
📊 Key Findings
•Standard dose may be suboptimal for EGFR/ALK+ tumors
•Dose escalation 🔛 to improved local control
•N🚫 significant ⬆️ in toxicity

[Dr. Luis A. Pérez-Romasanta @LuisAlberto3P]

Hablando de Radiobiología:
DOSIS BIOLOGICA EFECTIVA
¿Qué es?
¿Para qué sirve?
¿Cómo se utiliza?

[Dr. Foxpaws Fauxpas @foxpaws_onco]

Adjuvant therapies in Pancreatic Cancer.
Folfirinox (PRODIGE24)
✅ OS 54 v 35m ✅ mDFS 21 v 12m
Gem Cap (ESPAC4)
OS ✅ 28 vs 25m DFS ❌
Gem Nabpacli (APACT)
OS ✅ 40 v 36m, DFS ❌
Radiation (LAP07) ❌

What is routinely used in practice?
@SuyogCancer @OncBrothers

[Oren Gottfried, MD @OGdukeneurosurg]

Can anger ever be good for you and your brain?

[Nicholas Zaorsky, MD MS @NicholasZaorsky]

Guiding Treatment for Patients With Prostate Cancer With Biochemical Recurrence After Prostatectomy
https://t.co/2TF9uZEFk7
with @AmarUKishan @DrSpratticus

Thanks @ASCO Daily News

Related @NatRevUrol article: https://t.co/AFzrHLoEYW
https://t.co/kfBMkjK6lD

[SBRT memes for hypofractionated teens @sbrtmemes]

🧠⚡️
#radonc

[gilberto lopes @GlopesMd]

https://t.co/sjY17xnyCa
Our meta-analysis aggregates data from more the 30 studies comprising 3000+ patients, showing that ctDNA decrease and clearance are strongly associated with PFS and OS in lung cancer. Results hold true for targeted treatments and immunotherapy! @iaslc #LCSM @GuardantHealth @LucenceHealth @ASCO @uicc Time is ripe to include as outcome in prospective studies so we can incorporate in decision making and drug approval process - @FDAOncology @JCOGO_ASCO @ASCOPost @JackWestMD @n8pennell @ChristianRolfo @StephenVLiu @myESMO @SylvesterCancer @cancermd @NarjustFlorezMD @Jani_Chinmay @Latinamd